These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2244928)

  • 1. Inhibitory effect of unstimulated neutrophils on platelet aggregation by release of a factor similar to endothelium-derived relaxing factor (EDRF).
    Nicolini FA; Mehta JL
    Biochem Pharmacol; 1990 Nov; 40(10):2265-9. PubMed ID: 2244928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative platelet inhibitory effects of human neutrophils and lymphocytes.
    Nicolini FA; Wilson AC; Mehta P; Mehta JL
    J Lab Clin Med; 1990 Aug; 116(2):147-52. PubMed ID: 2168463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary thromboembolism-induced alterations in nitric oxide release from rat circulating neutrophils.
    Dikshit M; Kumari R; Srimal RC
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1369-73. PubMed ID: 8510015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro.
    Faint RW; Mackie IJ; Machin SJ
    Br J Haematol; 1991 Apr; 77(4):539-45. PubMed ID: 1851034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium-derived relaxing factor (EDRF): a defence mechanism against platelet aggregation and vasospasm in human coronary arteries.
    Förstermann U; Mügge A; Alheid U; Bode SM; Frölich JC
    Eur Heart J; 1989 Nov; 10 Suppl F():36-43. PubMed ID: 2620689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the existence and biological role of L-arginine/nitric oxide pathway in human platelets by spin-trapping/EPR studies.
    Prónai L; Ichimori K; Nozaki H; Nakazawa H; Okino H; Carmichael AJ; Arroyo CM
    Eur J Biochem; 1991 Dec; 202(3):923-30. PubMed ID: 1662618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet effects of endothelium-derived relaxing factor and nitric oxide donors.
    Bassenge E
    Eur Heart J; 1991 Nov; 12 Suppl E():12-5. PubMed ID: 1665128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: blockade of aggregation and secretion by an aspirin-insensitive mechanism.
    Broekman MJ; Eiroa AM; Marcus AJ
    Blood; 1991 Aug; 78(4):1033-40. PubMed ID: 1868238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of vascular tone by neutrophils: dependence on endothelial integrity.
    Mehta JL; Lawson DL; Nichols WW; Mehta P
    Am J Physiol; 1989 Oct; 257(4 Pt 2):H1315-20. PubMed ID: 2508493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of platelet aggregation by a protein factor present in rat peripheral polymorphonuclear leukocyte supernatant.
    Kumari R; Singh MP; Seth P; Dikshit M
    Thromb Res; 1998 Jul; 91(2):75-82. PubMed ID: 9722023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets.
    Alheid U; Frölich JC; Förstermann U
    Thromb Res; 1987 Sep; 47(5):561-71. PubMed ID: 3499684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of prostacyclin, EDRF and active oxygens in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro.
    Hirafuji M; Shinoda H
    Br J Pharmacol; 1993 Jun; 109(2):524-9. PubMed ID: 8358552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation.
    Furlong B; Henderson AH; Lewis MJ; Smith JA
    Br J Pharmacol; 1987 Apr; 90(4):687-92. PubMed ID: 3495310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of guanylate cyclase and inhibition of platelet aggregation by endothelium-derived relaxing factor released from cultured cells.
    Hawkins DJ; Meyrick BO; Murray JJ
    Biochim Biophys Acta; 1988 May; 969(3):289-96. PubMed ID: 2897209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of platelet cyclic GMP but not cyclic AMP suppression in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro.
    Hirafuji M; Nezu A; Shinoda H; Minami M
    Br J Pharmacol; 1996 Jan; 117(2):299-304. PubMed ID: 8789382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor.
    Salvemini D; de Nucci G; Gryglewski RJ; Vane JR
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6328-32. PubMed ID: 2548208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of collagen- and ADP-induced platelet aggregation by substance P in vivo: involvement of endothelium-derived relaxing factor.
    Humphries RG; Tomlinson W; O'Connor SE; Leff P
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):292-7. PubMed ID: 1697386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells.
    Martin W; White DG; Henderson AH
    Br J Pharmacol; 1988 Jan; 93(1):229-39. PubMed ID: 2894877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor.
    Stamler J; Mendelsohn ME; Amarante P; Smick D; Andon N; Davies PF; Cooke JP; Loscalzo J
    Circ Res; 1989 Sep; 65(3):789-95. PubMed ID: 2548765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
    Salvemini D; Currie MG; Mollace V
    J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.